HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,011 Cr | ₹933 Cr | ₹662 Cr | ₹828 Cr | ₹703 Cr |
What is the latest Total Current Liabilities ratio of HIKAL ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,011 Cr |
| Mar2024 | ₹933 Cr |
| Mar2023 | ₹662 Cr |
| Mar2022 | ₹828 Cr |
| Mar2021 | ₹703 Cr |
How is Total Current Liabilities of HIKAL Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,011 Cr | 8.36 | |
| Mar2024 | ₹933 Cr | 41.00 | |
| Mar2023 | ₹662 Cr | -20.12 | |
| Mar2022 | ₹828 Cr | 17.75 | |
| Mar2021 | ₹703 Cr | - | |
Compare Total Current Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,290.3 Cr | -7.5% | -0.8% | -43.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -7.5% |
-0.8% |
-43.7% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses